Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Pharmacia scientists report novel telomerase inhibitors in a recent patent

Feb. 11, 2004

Enrollment ceased in phase III NSCLC study of Sarasar

Feb. 10, 2004

Novel steroid sulphate inhibitor for breast tumor therapy reported

Feb. 10, 2004

AP-5346 makes preclinical and clinical progress

Feb. 9, 2004

Alimta approved for use with cisplatin for malignant pleural mesothelioma

Feb. 9, 2004

Orphan drug status for BCX-1777 for T-cell non-Hodgkin's lymphoma

Feb. 9, 2004

DepoCyte launched in Europe

Feb. 9, 2004

French team reports novel proapoptitic and antiangiogenic agents for cancer therapy

Feb. 9, 2004

Abbott and Caprion collaborate on drug discovery for lung cancer

Feb. 9, 2004

Phase I ThermoDox protocol amendments allowed

Feb. 6, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...